Compounds > rc 3095
Page last updated: 2024-09-03

rc 3095 and Cancer of Prostate

rc 3095 has been researched along with Cancer of Prostate in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (75.00)18.2507
2000's0 (0.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bajo, AM; Carmena, MJ; Muñoz-Moreno, L; Prieto, JC; Sánchez-Chapado, M; Schally, AV; Sotomayor, S1
Jiang, YF; Wu, B; Xu, Y1
Halmos, G; Pinski, J; Schally, AV; Szepeshazi, K2
Groot, K; Halmos, G; Pinski, J; Reile, H; Schally, AV1
Halmos, G; Pinski, J; Schally, AV1
Getzenberg, RH; Konety, BR1
Groot, K; Milovanovic, SR; Radulovic, S; Schally, AV1

Reviews

2 review(s) available for rc 3095 and Cancer of Prostate

ArticleYear
New agonist- and antagonist-based treatment approaches for advanced prostate cancer.
    The Journal of international medical research, 2012, Volume: 40, Issue:4

    Topics: Animals; Antineoplastic Agents, Hormonal; Bombesin; Clinical Trials as Topic; Humans; Leuprolide; Male; Neoplasms, Hormone-Dependent; Octreotide; Oligopeptides; Peptide Fragments; Prostatic Neoplasms; Sermorelin

2012
Novel therapies for advanced prostate cancer.
    Seminars in urologic oncology, 1997, Volume: 15, Issue:1

    Topics: Animals; Antineoplastic Agents; Bombesin; Diet; Enzyme Inhibitors; Epoprostenol; Genetic Therapy; Humans; Imidazoles; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Ornithine Decarboxylase Inhibitors; Peptide Fragments; Polyamines; Prostatic Neoplasms; Suramin; Vitamins

1997

Other Studies

6 other study(ies) available for rc 3095 and Cancer of Prostate

ArticleYear
Regulation of HER expression and transactivation in human prostate cancer cells by a targeted cytotoxic bombesin analog (AN-215) and a bombesin antagonist (RC-3095).
    International journal of cancer, 2010, Oct-15, Volume: 127, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Bombesin; Cell Proliferation; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Male; Peptide Fragments; Prostatic Neoplasms; Receptor, ErbB-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcriptional Activation; Tumor Cells, Cultured

2010
Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice.
    International journal of cancer, 1993, Dec-02, Volume: 55, Issue:6

    Topics: Animals; Antineoplastic Agents; Bombesin; Carcinoma; Cell Division; ErbB Receptors; Male; Mice; Mice, Nude; Neoplasm Transplantation; Organ Size; Peptide Fragments; Prostatic Neoplasms; Receptors, Bombesin; Receptors, Somatostatin; Somatostatin; Transplantation, Heterologous; Tumor Cells, Cultured

1993
Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Cancer research, 1994, Jan-01, Volume: 54, Issue:1

    Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Bombesin; Castration; Cell Division; Drug Screening Assays, Antitumor; ErbB Receptors; Gastrins; Growth Hormone; Male; Molecular Sequence Data; Neoplasm Transplantation; Peptide Fragments; Prostatic Neoplasms; Rats; Somatostatin

1994
Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice.
    Cancer letters, 1993, Jul-30, Volume: 71, Issue:1-3

    Topics: Amino Acid Sequence; Androgens; Animals; Binding Sites; Body Weight; Bombesin; Cell Line; Gastrin-Releasing Peptide; Gastrins; Growth Hormone; Humans; Male; Mice; Mice, Nude; Molecular Sequence Data; Peptide Fragments; Peptides; Prostatic Neoplasms; Somatostatin

1993
Antagonists of bombesin/gastrin-releasing peptides as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Cancer, 1993, Dec-01, Volume: 72, Issue:11

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bombesin; Connective Tissue; ErbB Receptors; Gastrin-Releasing Peptide; Gonadotropin-Releasing Hormone; Male; Mitosis; Peptide Fragments; Peptides; Prostatic Neoplasms; Rats; Rats, Inbred F344; Rats, Inbred Strains; Receptor, IGF Type 1; Receptors, Bombesin; Testosterone; Time Factors

1993
Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160.
    The Prostate, 1992, Volume: 20, Issue:4

    Topics: Amino Acid Sequence; Animals; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bombesin; Cell Division; Gonadotropin-Releasing Hormone; Hormones; Humans; Insulin-Like Growth Factor I; Kinetics; Male; Mice; Mice, Nude; Molecular Sequence Data; Organ Size; Peptide Fragments; Prostate-Specific Antigen; Prostatic Neoplasms; Somatostatin; Transplantation, Heterologous; Triptorelin Pamoate

1992